Interactions Between Therapeutics for Metabolic Disease, Cardiovascular Risk Factors, and Gut Microbiota

Interactions Between Therapeutics for Metabolic Disease, Cardiovascular Risk Factors, and Gut Microbiota

With improved standards of living, the incidence of multiple metabolic disorders has increased year by year, especially major risk factors for cardiovascular disease such as hyperglycemia and hyperlipidemia, continues to increase. Emerging epidemiological data and clinical trials have shown the addi...

Full description

Bibliographic Details
Main Authors: Qi-You Ding, Jia-Xing Tian, Min Li, Feng-Mei Lian, Lin-Hua Zhao, Xiu-Xiu Wei, Lin Han, Yu-Jiao Zheng, Ze-Zheng Gao, Hao-Yu Yang, Xin-Yi Fang, Xiao-lin Tong
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
metabolic therapy
gut microbiota
cardiovascular diseases
metformin
microbiota-targeted therapies
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2020.530160/full

Internet

https://www.frontiersin.org/articles/10.3389/fcimb.2020.530160/full

Similar Items